Professor, Internal Medicine, University of Utah School of Medicine
Nephrology
Dr. Alfred K. Cheung, MD
|
|
Give Review
Alfred K. Cheung works in the field of Nephrology. He went to Albany Medical College. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Alfred K. Cheung, MD is a published doctor. He has 100 publications published. The most current publication "Enhanced fluid removal guided by blood volume monitoring during chronic hemodialysis." Dr. Alfred K. Cheung accepts Medicare.
Publications
- Association of Vascular Access Type With Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.
- A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
- Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics.
- Managing Hypertension in Patients With CKD: A Marathon, Not a SPRINT.
- Aberrant Soluble Epoxide Hydrolase and Oxylipin Levels in a Porcine Arteriovenous Graft Stenosis Model.
- Race/Ethnicity, Age, and Risk of Hospital Admission and Length of Stay during the First Year of Maintenance Hemodialysis.
- The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Tria...
- Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and Renal oxidative stress and inflammation.
- Adiponectin retards the progression of diabetic Nephropathy in db/db mice by counteracting angiotensin II.
- Measurement of renal tissue oxygenation With Blood Oxygen Level Dependent (BOLD) MRI and oxygen transit modeling.
- A PAI-1 mutant retards diabetic Nephropathy in db/db mice through protecting podocytes.
- New magnetic resonance imaging methods in nephrology.
- Facility Size, Race and Ethnicity, and Mortality for In-Center Hemodialysis.
- Objectives and Design of the Hemodialysis Fistula Maturation Study.
- Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis.
- The relationship of age, race, and ethnicity With survival in dialysis patients.
- The Associations between Race and Geographic Area and Quality-of-Care Indicators in Patients Approaching ESRD.
- Low Body Mass Index and Dyslipidemia in Dialysis Patients Linked to Elevated Plasma Fibroblast Growth Factor 23.
- Serial analysis of lumen geometry and hemodynamics in human arteriovenous fistula for hemodialysis using magnetic resonance imaging and computational fluid dynamics.
- Serum bicarbonate and mortality in adults in NHANES III.
- Targeting reduction of proteinuria in glomeruloNephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes.
- Associations of Serum Skeletal Alkaline Phosphatase With Elevated C-Reactive Protein and Mortality.
- Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
- A biodegradable perivascular wrap for controlled, local and directed drug delivery.
- In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft s...
- Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study.
- Implications of the frequent hemodialysis network-daily trial.
- Kinetic Model of Phosphorus Mobilization during and after Short and Conventional Hemodialysis.
- ?-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.
- Intradialytic Hypotension and vascular access thrombosis.
- Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
- OPPORTUNITYTM: a large-scale randomized clinical trial of growth hormone in hemodialysis patients.
- Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic Kidney disease.
- Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular grafts.
- PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms.
- Efficacy and safety of carvedilol in treatment of heart failure with chronic Kidney disease: a meta-analysis of randomized trials.
- Both low muscle mass and low fat are associated With higher all-cause mortality in hemodialysis patients.
- Blood pressure in chronic Kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.
- Is lipid control necessary in hemodialysis patients?
- Serum alkaline phosphatase and mortality in African Americans with chronic Kidney disease.
- In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation.
- Effect of membrane permeability on survival of hemodialysis patients.
- Using the stochastic collocation method for the uncertainty quantification of drug concentration due to depot shape variability.
- Longitudinal assessment of hyperplasia using magnetic resonance imaging Without contrast in a porcine arteriovenous graft model.
- Neointimal hyperplasia associated With synthetic hemodialysis grafts.
- OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients.
- Disordered mineral Metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.
- Pathogenesis and local drug delivery for prevention of vascular access stenosis.
- The association of lipid-modifying medications With mortality in patients on long-term peritoneal dialysis.
- Lipoprotein metabolism and lipid management in chronic Kidney disease.
- Lack of synergistic effects of metabolic Syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
- Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
- Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
- Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells.
- Development of a sustained-release system for perivascular delivery of dipyridamole.
- Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
- Perivascular tissue pharmacokinetics of dipyridamole.
- Revisiting the hemodialysis dose.
- Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.
- Associations of metabolic syndrome With inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
- The role of pretransplantation renal replacement therapy modality in Kidney allograft and recipient survival.
- Different responses by cultured aortic and venous smooth muscle cells to gamma radiation.
- Dialyzer membranes as determinants of the adequacy of dialysis.
- Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
- Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments.
- Association of obesity with inflammation in chronic Kidney disease: a cross-sectional study.
- Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs.
- Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.
- Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction.
- Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.
- Impact of timing of initiation of dialysis on mortality.
- Creatinine production, nutrition, and glomerular filtration rate estimation.
- Hollow fiber shape alters solute clearances in high flux hemodialyzers.
- Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis.
- Impact of renal Failure on the risk of myocardial infarction and death.
- The career of Lee W. Henderson.
- Relationship between volume status and blood pressure during Chronic hemodialysis.
- Increased protein loss during peritonitis associated With peritoneal dialysis is neutrophil dependent.
- Hemodialysis membrane biocompatibility: the case of erythropoietin.
- Characterization of molecular transport in artificial Kidneys.
- Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis.
- Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro.
- Complement activation as index of haemodialysis membrane biocompatibility: the choice of methods and assays.
- Analysis of the complement C3 fragments associated With hemodialysis membranes.
- Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
- Quantitation of dialysis. The importance of membrane and middle molecules.
- Enhanced fluid removal guided by blood volume monitoring during Chronic hemodialysis.
- Modulation of complement activation on hemodialysis membranes by immobilized heparin.
- A prospective study on treatment of hypercholesterolemia With lovastatin in renal transplant patients receiving cyclosporine.
- Biocompatibility of hemodialysis membranes.
- Activation of the alternative pathway of complement by cellulosic hemodialysis membranes.
- Treatment of nephrotic hyperlipoproteinemia With gemfibrozil.
- Improving general practitioners'' interviewing skills in managing patients With depression and anxiety: a randomized controlled clinical trial.
- Urea movement across erythrocyte membrane during artificial Kidney treatment.
- Stages of future technological developments in haemodialysis.
- Biomedical polymers differ in their capacity to activate complement.
- Reducing symptoms during hemodialysis by continuously monitoring the hematocrit.
- Generalized beta 2-microglobulin deposition. A preamyloidosis disorder?
- Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Schools
Albany Medical College
Loma Linda University Med Center
University Of California San Diego
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Loma Linda University -
Albany Medical College
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1811087406 | |
| NPPES Provider LastName | CHEUNG | |
| NPPES Provider FirstName | ALFRED | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | Nephrology | |
| Total Claim Count | 93.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811087406 |
| Last Name Of The Provider | CHEUNG |
| First Name Of The Provider | ALFRED |
| View All |
Similar Doctors
|
|
Dr. Arasu Gopinath, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald S. Bloom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wayne A. Border, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron A. Fearday, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Bond, MD |
|
|
Dr. Josephine D. Abraham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monique E. Cho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dave T. Tien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Barklow, MD |
|
|
Macy A. Martinson |